ReviewCureus2025
Role of Enhanced Recovery After Surgery (ERAS) Protocols in Arthroplasty: A Systematic Review of RCTs and Prospective Studies (2018-2024).
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- 5E management protocol for enhanced recovery after total knee arthroplasty: stratified RCT.Journal of orthopaedic surgery and research · 2026Trial
- Pain Management Strategies in Reverse Total Shoulder Arthroplasty.Current reviews in musculoskeletal medicine · 2026Review
- Optimization of perioperative nutrition management based on the ERAS protocol for improving postoperative recovery in patients undergoing total knee arthroplasty: a prospective comparative study.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Enhanced Recovery After Surgery (ERAS) protocols constitute evidence-based intervention pathways prepared to decrease surgical stress, maintain physiological function, and improve recovery. This study aimed to systematically review the ERAS effect after primary total hip arthroplasty (THA) or total knee arthroplasty (TKA) on patients' clinical outcomes. This systematic review was developed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Online search was done through MEDLINE, PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), Scopus, and Ovid. The search included the time from 2018 to 2024. The inclusion criteria included prospective nonrandomized cohort studies and RCTs that compared adult patients undergoing primary THA or TKA with ERAS or traditional (control) protocols. Studies that were conducted among patients with trauma and malignancies were excluded. The primary outcome was the length of hospital stay. The secondary outcomes included operation time, readmission rate, and intraoperative blood losses. Of the 642 records identified, six studies met the inclusion criteria. In total, 7206 individuals were analyzed, of whom 2148 underwent ERAS (intervention), and 5058 underwent traditional care either as a control or a pre-intervention group. Narrative synthesis was performed, and the ERAS interventions were divided into preoperative, intraoperative, and postoperative interventions. The systematic review showed that ERAS protocols significantly reduced hospital length of stay. There was no significant effect on readmission rates. However, intraoperative blood losses significantly decreased with the application of ERAS protocols. Regarding THA and TKA, ERAS protocols significantly decreased the length of hospitalization. The effect of readmission was comparable between the intervention and control groups. The impact of ERAS on operation duration was inconclusive. Further research is needed to assess and analyze the definitive impact of each component of the ERAS protocol on total joint arthroplasty.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.